Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women

Journal of the National Cancer Institute

Volumn 92, Issue 19, 2000, Pages 1592-1600

  Kaaks, Rudolf ^a   Toniolo, Paolo ^b   Akhmedkhanov, Arslan ^b   Lukanova, Annekatrin ^a   Biessy, Carine ^a   Dechaud, Henri ^c   Rinaldi, Sabina ^a   Zeleniuch Jacquotte, Anne ^b   Shore, Roy E ^b   Riboli, Elio ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hopital de l'Antiquaille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; UNITED STATES;

EID: 0034605463     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.19.1592     Document Type: Article

References (51)

1. Nutrition and colorectal cancer
2. Insulin and colon cancer
3. Dietary fiber-mediated mechanisms in carcinogenesis
4. Physical activity, obesity, and risk for colon cancer and adenoma in men
5. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group
6. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?
7. Insulin-like growth factors and their binding proteins: Biological actions
8. The role of the insulin-like growth factor system in human cancer
9. Insulinlike growth factors and binding proteins in colon cancer
10. Nutritional regulation of the insulin-like growth factors
11. Nutritional regulation of hormones and growth factors that control mammalian growth
12. The role of calories and caloric restriction in carcinogenesis
13. Caloric restriction as a mechanism mediating resistance to environmental disease
14. Increased blood glucose and insulin, body size, and incident colorectal cancer
15. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
16. C-peptide measurement: Methods and clinical utility
17. How to measure insulin secretion
18. The PHREG procedure
19. Tobacco, colorectal cancer, and adenomas: A review of the evidence
20. Comparison of active and Cancer registry-based follow-up for breast cancer in a prospective cohort study
21. Banting lecture 1988. Role of insulin resistance in human disease
22. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
23. Insulin-like growth factor binding proteins and their role in controlling IGF actions
24. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
25. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (Bp)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
26. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus
27. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients With anorexia nervosa: Effect of short-and long-term weight recuperation
28. Free insulin-like growth factors in human obesity
29. Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
30. Post-load plasma glucose and cancer mortality in middie-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry
31. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
32. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
33. Diabetes mellitus and colorectal cancer risk
34. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
35. Risk factors for colorectal cancer in Subjects with family history of the disease
36. Diabetes mellitus and risk of large bowel cancer
37. Diabetes mellitus and cancer risk: A multisite case-control study
38. Radioimmunoassays for IGFs and IGFBPs
39. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native ahd acid-ethhhol-extracted serum
40. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study
41. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: Relation to age and sex steroid levels
42. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3
43. Regulation of hepatic growth hormone receptors by insulin
44. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus
45. Growth hormone-binding proteins in plasma
46. Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation via brain
47. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor (IGF-I) evidence for a suppressive action of free rather than bound IGF-I I
48. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29
49. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line
50. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26
51. Insulin-like growth factor binding proteins